GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations

被引：0
|
作者：
Paolo Sportoletti
Letizia Celani
Emanuela Varasano
Roberta Rossi
Daniele Sorcini
Chiara Rompietti
Francesca Strozzini
Beatrice Del Papa
Valerio Guarente
Giulio Spinozzi
Debora Cecchini
Oxana Bereshchenko
Torsten Haferlach
Maria Paola Martelli
Franca Falzetti
Brunangelo Falini
机构：
[1] University of Perugia,Centro di Ricerca Emato
[2] University of Perugia,Oncologica (CREO)
[3] MLL Munich Leukemia Laboratory,Section of Pharmacology, Toxicology and Chemotherapy
来源：
Leukemia | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1827 / 1832
页数：5
相关论文
共 50 条
  • [41] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Kim, Dennis D.
    Thyagu, Santhosh
    Messner, Hans A.
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 368 - 374
  • [42] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey
    Viswabandya, Auro
    Kim, Dennis
    Thyagu, Santhosh
    Messner, Hans
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2018, 53 : 169 - 170
  • [43] Validation of the ELN 2017 Classification for AML with Intermediate Risk Cytogenetics with or without NPM1 - Mutations and High or Low Ratio FLT3-ITD s
    Schetelig, Johannes
    Rollig, Christoph
    Kayser, Sabine
    Stoelzel, Friedrich
    Schaefer-Eckart, Kerstin
    Haenel, Mathias
    Roesler, Wolf
    Einsele, Hermann
    Kaufmann, Martin
    Serve, Hubert
    Bug, Gesine
    Kraemer, Alwin
    Berdel, Wolfgang E.
    Stelljes, Matthias
    Mayer, Jiri
    Reichle, Albrecht
    Baldus, Claudia D.
    Schmitz, Norbert
    Middeke, Jan Moritz
    Kramer, Michael
    Ehninger, Gerhard
    Bornhauser, Martin
    Thiede, Christian
    BLOOD, 2017, 130
  • [44] Clinical relevance of NPM1 and FLT3 mutations in AML patients
    Blau, O.
    Baldus, C. D.
    Graul, K.
    Sindram, A.
    Thiel, E.
    Blau, I. W.
    ONKOLOGIE, 2010, 33 : 234 - 234
  • [45] PROGNOSTIC IMPACT OF WHITE BLOOD CELL COUNT IN INTERMEDIATE RISK AML: RELEVANCE OF MUTATED NPM1 AND FLT3-ITD
    de Jonge, J. M. Hendrik
    Valk, J. M. Peter
    de Bont, S. J. M. Eveline
    Schuringa, Jan Jacob
    Ossenkoppele, Gert
    Vellenga, Edo
    Huls, Gerwin
    ANNALS OF HEMATOLOGY, 2011, 90 : S5 - S5
  • [46] Eccentricity of Acute Myeloid Leukemia with NPM1 and FLT3-ITD Mutation: A Case Report
    Zainura, Nur M.
    Suzana, Alia A.
    Salwati, S.
    Rafeah, Nor T.
    Suria, A.
    MEDICINE AND HEALTH, 2022, 17 (02): : 305 - 313
  • [47] "Cup-like" blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML)
    Jain, Preetesh
    Vega-Vazquez, Francisco
    Faderl, Stefan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (01) : 3 - 3
  • [48] FLT3 AND NPM1 GENE MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIAS AND THE IMPACT OF FLT3-ITD MUTATIONS ON THE SURVIVAL OF PATIENTS WITH A NORMAL KARYOTYPE
    Martynkevich, I. S.
    Gritsayev, S. V.
    Moskalenko, M. V.
    Ivanova, M. P.
    Aksenova, V. Yu
    Tiranova, S. A.
    Abdulkadyrov, K. M.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (12) : 33 - 39
  • [49] 中国AML人群CEBPa、NPM1、FLT3-ITD基因突变发生率检测
    廖长风
    刘礼平
    赖文鸿
    林传明
    李海亮
    赣南医学院学报, 2016, 36 (02) : 208 - 211
  • [50] The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse
    Kurosawa, Saiko
    Yamaguchi, Hiroki
    Yamaguchi, Takuhiro
    Fukunaga, Keiko
    Yui, Shunsuke
    Kanamori, Heiwa
    Usuki, Kensuke
    Uoshima, Nobuhiko
    Yanada, Masamitsu
    Takeuchi, Jin
    Mizuno, Ishikazu
    Kanda, Junya
    Okamura, Hiroshi
    Yano, Shingo
    Tashiro, Haruko
    Shindo, Takero
    Chiba, Shigeru
    Tomiyama, Junji
    Inokuchi, Koiti
    Fukuda, Takahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (02) : 200 - 209
12345